Phase I/II Radiation Dose-Escalation Trial of Intensity Modulated Radiotherapy (IMRT) with Concurrent Fixed Dose-Rate Gemcitabine (FDR-G) for Unresectable Pancreatic Cancer

被引：4
|
作者：
Ben-Josef, E. [1 ]
Schipper, M. [1 ]
Francis, I. [1 ]
Khan, G. [1 ]
Hadley, S. [1 ]
Lawrence, T. [1 ]
Simeone, D. [1 ]
Abrams, R. [2 ]
Sonnenday, C. [1 ]
Zalupski, M. [1 ]
机构：
[1] Univ Michigan, Med Ctr, Ann Arbor, MI USA
[2] Rush Univ, Med Ctr, Chicago, IL 60612 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.263
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S127 / S128
页数：2
相关论文
共 50 条
  • [41] A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancer
    Justin A. Chen
    Jasmine C. Huynh
    Chun-Yi Wu
    Ai-Ming Yu
    Karen Matsukuma
    Thomas J. Semrad
    David R. Gandara
    Tianhong Li
    Jonathan W. Riess
    Kit Tam
    Philip C. Mack
    Anthony Martinez
    Nichole Mahaffey
    Karen L. Kelly
    Edward J. Kim
    Cancer Chemotherapy and Pharmacology, 2022, 90 : 217 - 228
  • [42] Phase I Trial of Stereotactic Body Radiation Therapy Dose Escalation in Pancreatic Cancer
    Courtney, P. Travis
    Paravati, Anthony J.
    Atwood, Todd F.
    Raja, Nandita
    Zimmerman, Collin T.
    Fanta, Paul T.
    Lowy, Andrew M.
    Simpson, Daniel R.
    Xu, Ronghui
    Murphy, James D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (04): : 1003 - 1012
  • [43] Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas:: a GEIS study
    Lopez-Pousa, A.
    Losa, R.
    Martin, J.
    Maurel, J.
    Fra, J.
    Sierra, M.
    Casado, A.
    Garcia del Muro, J.
    Poveda, A.
    Balana, C.
    Martinez-Trufero, J.
    Esteban, E.
    Buesa, J. M.
    BRITISH JOURNAL OF CANCER, 2006, 94 (12) : 1797 - 1802
  • [44] Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study
    A López-Pousa
    R Losa
    J Martín
    J Maurel
    J Fra
    M Sierra
    A Casado
    J García del Muro
    A Poveda
    C Balañá
    J Martínez-Trufero
    E Esteban
    J M Buesa
    British Journal of Cancer, 2006, 94 : 1797 - 1802
  • [45] Preliminary results of a phase II neoadjuvant trial with gemcitabine/oxaliplatin and cetuximab followed by surgery or concurrent intensity modulated radiation therapy (IMRT) with capecitabine for patients with borderline resectable and unresectable nonmetastatic pancreatic cancer
    Chaudhary, U. B.
    Gudena, V.
    Milling, D. L.
    O'Brien, P.
    Montero, A. J.
    Brashears, J.
    Marshall, D.
    Hoffman, B.
    Garrett-Mayer, E.
    Esnaola, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] GEMCITABINE (G) FIXED RATE DOSE INFUSION (FDR) PLUS ERLOTINIB (E) IN PATIENTS WITH ADVANCED PANCREATIC CANCER (APC)
    Munoz, A.
    Azkona, E.
    Iza, E.
    Martinez, M.
    Lopez-Vivanco, G.
    Fernandez, R.
    Ruiz De Lobera, A.
    Rubio, I.
    Casas, R.
    Mane, J. M.
    ANNALS OF ONCOLOGY, 2010, 21 : 235 - 235
  • [47] Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: A multicenter phase II trial
    Small, William, Jr.
    Berlin, Jordan
    Freedman, Gary M.
    Lawrence, Theodore
    Talamonti, Mark S.
    Mulcahy, Mary F.
    Chakravarthy, A. Bapsi
    Konski, Andre A.
    Zalupski, Mark M.
    Philip, Philip A.
    Kinsella, Timothy J.
    Merchant, Nipun B.
    Hoffman, John P.
    Benson, Al B.
    Nicol, Steven
    Xu, Rong M.
    Gill, John F.
    McGinn, Cornelius J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (06) : 942 - 947
  • [48] Phase II trial of neoadjuvant fixed dose rate (FDR) gemcitabine with capecitabine (GX) combination chemotherapy in locally advanced pancreatic adenocarcinoma (LAPA)
    Lee, J.
    Lee, S.
    Kim, T.
    Lee, J.
    Park, D.
    Seo, D.
    Lee, S.
    Kim, M.
    Han, D.
    Kim, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [49] A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer
    Cobleigh, MA
    Langmuir, VK
    Sledge, GW
    Miller, KD
    Haney, L
    Novotny, WF
    Reimann, JD
    Vassel, A
    SEMINARS IN ONCOLOGY, 2003, 30 (05) : 117 - 124
  • [50] 5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma: Phase I-II dose-escalation study
    Morganti, AG
    Valentini, V
    Macchia, G
    Mattiucci, GC
    Costamagna, G
    Deodato, F
    Smaniotto, D
    Luzi, S
    Balducci, M
    Barbi, S
    Perri, V
    Trodella, L
    Cellini, N
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (05): : 1454 - 1460
12345